Non-Autoimmune Musculoskeletal Conditions Flashcards
1
Q
Potentially beneficial interventions in osteoarthritis
A
Non-pharmacological
- Weight loss
- Exercise
- Patient education
- CBT
Pharmacological
- NSAIDs
- Duloxetine - modest effect, often poorly tolerated
- NGF inhibitors e.g. tanezumab
- Initial trials → effective analgesics but subsequently found to be A/W accelerated joint destruction and increased need for arthoplasty
- Intra-articular steroids → unlikely to get benefit beyond 2 months for knee joint infection. Regular injection → possible A/W accelerated joint destruction
Surgery
- Arthoplasty
2
Q
Interventions to avoid in osteoarthritis
A
- Fish oil, glucosamine, chondroitin
- Medications
- Paracetamol (no evidence of benefit)
- Opioids
- Gabepentinoids
- Glucocorticoids
- Intraarticular therapies except for glucocorticoids
- Arthroscopy
- No evidence for magnets/acupuncture/shock wave therapy/cold therapy/kinesio taping etc.
3
Q
Diagnostic criteria for fibromyalgia
A
4
Q
Management of fibromyalgia
A
- Goal may be improve function rather than abolish pain
- Avoid excessive use of caffeinated stimulants in patients with symptoms of fibrofog
- Careful evaluation of new symptoms to exclude other medical conditions
- Small doses of exercise → avoid exercise to exhaustion, with gradual dose increases
- Avoid opiates
- Treat other sources of nociceptive pain (e.g. osteoarthritis)
Pharmacological
- TCAs
- Gabapentinoids
- SNRIs
- Tramadol
- Low dose naltrexone
- Propranolol
Always start low with slow up-titration of medications
Interventions to avoid
- Opioids, paracetamol, NSAIDs, glucocorticoids, benzodiazepines, sparse evidence for cannabinoids → not currently recommended
5
Q
Risk factors for osteoarthritis
A
- Family history and genetics - esp. hip and knee
- Developmental problems: hip dysplasia, slipped femoral epiphyses
- Repetitive loading: athletes, manual workers, squatting
- Biomechanical: Paget’s, ligament rupture, menisectomy
- Obesity
- Trauma
- Hormonal: aromatase inhibitors, oestrogen deficiency
6
Q
Pathophysiology of osteoarthritis
A
- IL-1B, TNF, and IL-6 → pro-inflammatory cytokines involved
- IL-1B and TNF → downregulate synthesis of major ECM components by inhibiting anabolic activities of chondrocytes
- IL-1B downregulated expression of aggrecan and Type II collagen → structural components of cartilage & stimulates release of proteolytic enzymes → metalloproteinases MMP1, 3 and 13 → key regulators of cartilage destruction
7
Q
Radiographic findings in osteoarthtis
A
- Osteophytes
- Subchondral sclerosis
- Subchondral cysts